NCT00290992View on ClinicalTrials.gov

Rasburicase for Hyperuricemia

PHASE2CompletedINTERVENTIONAL

Enrollment

30

Participants

Timeline

Start Date

June 30, 2005

Primary Completion Date

April 30, 2006

Study Completion Date

April 30, 2006

Conditions

Nutritional and Metabolic Diseases

Interventions

DRUG

rasburicase (SR29142)

Trial Locations (1)

Unknown

Sanofi-Aventis, Tokyo

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Sanofi

INDUSTRY